Comment author:ChristianKl
09 October 2016 07:51:08PM
2 points
[-]
Actually, Big Pharma would LOSE billions if it works. There are only a few anti-virals, and none of them work well, and most need to be used in combinations.
No. Gilead manages to charge it's 1000$ per pill for an antiviral. If Draco for all viruses works it could also be sold for a similar price for a bunch of conditions like AIDS.
You could argue say that Gilead isn't really Big Pharma but Biotech but it still shows that there are companies that have no problem with bringing cures to market. Gilead also makes a lot of money.
The company that would bring a working drug to market that cures drugs like AIDS would make a lot of money even if a few other companies might lose billions from it.
Comment author:CellBioGuy
11 October 2016 12:14:40AM
*
1 point
[-]
Worth noting that if I understand the mode of action of these proteins and have correctly read the tested dosages in the papers out thus far, a treatment would be more along the lines of the antibody immunotherapy infusions that people get for some types of cancer than a pill for a systemic effect, with localized versions like a nebulizer applied to things like a strong lung infection. And it's likely to cause a temporary inflammatory effect as lots of cells (including ones with no viral infection or latent viruses that everyone and I mean everyone has) blow up. You probably don't take this for a cold.
Comment author:ChristianKl
11 October 2016 12:55:09PM
0 points
[-]
And it's likely to cause a temporary inflammatory effect as lots of cells (including ones with no viral infection or latent viruses that everyone and I mean everyone has) blow up.
Getting rid of all latent viruses might be a feature and not a bug.
= 27d567bc2d48d9f40e9ccc20ea370b15)
= 783df68a0f980790206b9ea87794c5b6)
= b715d02e85f7b3b4ae65ca3d3e450868)
Subscribe to RSS Feed
= f037147d6e6c911a85753b9abdedda8d)
Comments (9)
No. Gilead manages to charge it's 1000$ per pill for an antiviral. If Draco for all viruses works it could also be sold for a similar price for a bunch of conditions like AIDS.
You could argue say that Gilead isn't really Big Pharma but Biotech but it still shows that there are companies that have no problem with bringing cures to market. Gilead also makes a lot of money.
The company that would bring a working drug to market that cures drugs like AIDS would make a lot of money even if a few other companies might lose billions from it.
Worth noting that if I understand the mode of action of these proteins and have correctly read the tested dosages in the papers out thus far, a treatment would be more along the lines of the antibody immunotherapy infusions that people get for some types of cancer than a pill for a systemic effect, with localized versions like a nebulizer applied to things like a strong lung infection. And it's likely to cause a temporary inflammatory effect as lots of cells (including ones with no viral infection or latent viruses that everyone and I mean everyone has) blow up. You probably don't take this for a cold.
And it's likely to cause a temporary inflammatory effect as lots of cells (including ones with no viral infection or latent viruses that everyone and I mean everyone has) blow up.
Getting rid of all latent viruses might be a feature and not a bug.